“Providing Your Innovative Benefits Solutions” Over-the-Counter Products October 2009
Information Update for Group Benefits Plan Sponsors and Administrators ________________________________________________________________ Effective January 1, 2010 Health Canada is re-classifying certain over-the- counter (OTC) products as NATURAL HEALTH PRODUCTS. The intent of this change is to distinguish “Natural Health Products” from “Drugs”. This new regulated change will help to ensure that these products are approved for sale in Canada and labeled appropriately, giving Canadians access to products that are safe, effective and of high quality. What effect will these changes have on Health Risk Services (HRS) plans? Today, HRS plans cover drugs that have been prescribed by an eligible prescriber, that are approved by Health Canada and that have a valid Drug Identification Number (DIN). Since most OTCs will no longer have valid DINs, they will generally NOT be eligible for coverage under HRS plans staring January 1, 2010. How will the new regulations affect the current drug identification? Effective January 2, 2010 most manufacturers of OTCs MUST COMPLY with Canada’s natural health product regulations, which came into effect in 2004. This means that certain OTCs must include an eight-digit natural product number (MPN) or drug identification number – homeopathic medicine (DIN-HM) from Health Canada. The DINs for existing OTCs that qualify as natural health products will be discontinued. At this time, it’s not known exactly which OTC products will be re-classified as natural health products, since manufacturers must apply for NPNs. Will Life-sustaining OTCs continue to be covered? YES. Life-sustaining OTCs, such as nitroglycerin, insulin, diabetic test strips, lancets, syringes, auto-injectors and glucagons, will retain their DINs and continue to be covered. Will vitamins and minerals be covered? Only injectable vitamins and prescription-strength vitamins will continue to be covered, since these vitamins will retain their DINs. Other vitamins will not be covered. OTC minerals, such as fluoride, iron, potassium and magnesium, will not be covered. Will Smoking cessation continue to be covered? Yes. For plans with smoking cessation coverage, products that require a prescription by law will continue to be covered. Other products will not be covered. Please Note: There may be some inconsistency in coverage of OTC products due to pharmacies potentially stocking the same product with both DIN labeling and NPN or DIN-HM labeling. For example, if a pharmacy dispenses an OTC product with DIN labeling, the product may be eligible for coverage under your HRS plan. If a pharmacy dispenses the same OTC product with NPN or DIN-HM labeling, the product will not be eligible for coverage under HRS plans as reclassification of natural health products continues. For more information on the new drug regulations, or to request that a policy amendment be initiated, please contact Luene La Fountaine of Health Risk Services Inc. at 403-236-9430 or 1-877- 236-9430 or [email protected] DISCLAIMER: The information contained in this YOUR BENEFITS UPDATE contains the views of Health Risk Services Inc. at the time this communication was prepared. Although the contents are believed to be correct, this is not intended to be tax or legal advice. You are encouraged to obtain a legal or financial opinion of your own in this regard. Errors and Omissions Insurance applies.
Erectile Dysfunction and Constructs of Masculinity and Quality of Life in the Multinational Men’s Attitudes to Life Events and Sexuality (MALES) Study Michael S. Sand, PhD, MPH,* William Fisher, PhD,† Raymond Rosen, PhD,‡ Julia Heiman, PhD,§ andIan Eardley, MD¶*Bayer Schering Pharma AG, Wuppertal, Germany; †University of Western Ontario, London, Ontario, Canada;‡New England Researc
T E R M O D E C O N S E N T I M E N T O E S C L A R E C I D O SERVIÇO DE DIÁLISE Hipolipemiantes Eu, __________________________________________________________________ (nome do (a) paciente), abaixo identificado (a) e firmado (a), declaro ter sido informado (a) claramente sobre todas as indicações, contra-indicações, principais efeitos colaterais e riscos relacionados ao us